HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 422537Generated: October 23, 2026
Piperazine → 4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl ester
https://huagongshe.com/en/reaction/422537
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | 1-Piperazinecarboxylic acid, ethyl ester | HCID 8431 | — |
| Reactant | Sulfuryl fluoride | HCID 17607 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 2-Chloro-5-(fluorosulpho)benzoic acid | HCID 88873 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | 4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl ester | HCID 45464231 | 80.8% |
Reaction Steps
2-Chloro-5-fluorosulfonylbenzoic acid (Acros Organics, 105 mg, 440 μmol, 1.0 eq) was placed in a vial and the vial was flushed with nitrogen and a positive pressure was maintained. Anhydrous dichloromethane (1.4 mL) was added, followed by ethyl 1-piperazine carboxylate (80 μL, 528 μmol, 1.2 eq) and ethyldiisopropylamine (redistilled, 80 μL, 440 μmol, 1.0 eq). The miXture was stirred for 1.5 h after which time additional piperazine was added (60 μL, 352 μmol, 0.8 eq). After 14 h the mixture was analyzed by reverse-phase HPLC-MS in negative ionization mode. The sulfonyl fluoride starting material was present, as well as a less polar compound showing (M-1) ion in about 35:65 ratio. An additional 0.35 eq of piperazine and ethyldiisopropylamine each (154 μmol, 30 μl) were added and the mixture was stirred for 4 h. HPLC-MS at this time indicated little progress and an additional 0.25 eq of piperazine (100 μmol, 20 μl) was added. After stirring for 14 h HPLC-MS indicated the reaction was complete. The reaction mixture was diluted with 2 mL of ethyl acetate, washed with 1M HCl solution (2×1 mL) and dried over anhydrous sodium sulfate. The solution was filtered, the solvents removed on a rotary evaporator and vacuum pump to afford 134 mg of a white solid, 81%. NOTE: Addition of excess nucleophilic amine at the beginning of the reaction results in significant bis addition, giving sulfonamide and carboxamide product. Stepwise addition of nucleophilic amine as needed suppresses formation of this side product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08101620B2 |
|---|
| Source dataset | uspto-grants-2012_01 |
|---|
| ORD ID | ord-910d20ff94d743b78e9c75279b8bb5bb |
|---|
| Source note | uspto-grants-2012_01 |
|---|